|

B7-H3-CAR T cells Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: CAR T- cell infusion

Pipeline

Phase 1: 2

Top Sponsors

  • St. Jude Children's Research Hospital2

Indications

  • Ewing Sarcoma2
  • Cancer2
  • Germ Cell Cancer1
  • Adrenocortical Cancer1
  • Malignant Peripheral Nerve Sheath Tumors1

Memphis, Tennessee2 trials

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

St. Jude Children's Research Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.